ATHE
Alterity Therapeutics
ATHE
ATHE
17 hedge funds and large institutions have $342K invested in Alterity Therapeutics in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
62% less capital invested
Capital invested by funds: $902K → $342K (-$560K)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$38K | |
| 2 | +$9.61K | |
| 3 | +$5.45K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1K |
Top Sellers
| 1 | -$70K | |
| 2 | -$10.8K | |
| 3 | -$4.84K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$904 |
| 5 |
AIM
Advantage Investment Management
Cedar Rapids,
Iowa
|
-$589 |